Internal Medicine, Endocrinology, Diabetes, & Metabolism · Pittsburgh, PA
NPI
1356607014
Since 2012
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
1400 Locust St Ste 5120, Suite 5120
Pittsburgh, PA, 15219
Phone (412) 232-9150
Groups this clinician bills Medicare through
Medicare paid, 2024
$22K
443 services
Medicare patients, 2024
161
Average age 73
Drug cost, 2024
$926K
2,048 prescriptions
Company payments, 2025
$365
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Karen Selk was code 99232 (hospital e&m - subsequent), 76 times for 30 patients. In total Karen Selk billed 443 services in 14 codes, and Medicare paid $22K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-03-25.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 76 | 30 | $57.50 | $4,370 |
| 99214 Office E&M - Established | Office | 67 | 51 | $76.09 | $5,098 |
| 99231 Hospital E&M - Subsequent | Facility | 43 | 25 | $37.48 | $1,612 |
| 95251 Test - Miscellaneous | Office | 32 | 19 | $24.65 | $789 |
| 99222 Hospital E&M - Initial | Facility | 29 | 28 | $87.30 | $2,532 |
| 99213 Office E&M - Established | Office | 21 | 21 | $57.70 | $1,212 |
| 99204 Office E&M - New | Office | 13 | 13 | $79.73 | $1,037 |
| 99221 Hospital E&M - Initial | Facility | 12 | 12 | $62.64 | $752 |
By year: 2022 $24K for 542 services; 2023 $22K for 410 services; 2024 $22K for 443 services.
Medicare prescription drug claims, 2024
In 2024, the drug Karen Selk prescribed most often to Medicare patients was Lantus Solostar (Insulin Glargine,hum.Rec.Anlog), with 141 prescriptions and refills. In total Karen Selk wrote 2,048 Medicare prescriptions that cost $926K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 141 | 321 | 39 | $14K |
| Levothyroxine Sodium Generic | 137 | 369 | 39 | $1,615 |
| Trulicity Dulaglutide | 115 | 135 | 24 | $129K |
| Mounjaro Tirzepatide | 110 | 140 | 20 | $145K |
| Metformin Hcl Er Metformin Hcl | 106 | 260 | 34 | $1,005 |
| Ozempic Semaglutide | 102 | 142 | 24 | $135K |
| Metformin Hcl Generic | 83 | 181 | 20 | $937 |
| Methimazole Generic | 80 | 118 | 13 | $508 |
| Jardiance Empagliflozin | 75 | 158 | 23 | $85K |
| Humalog Kwikpen U-100 Insulin Lispro | 73 | 125 | 27 | $20K |
| Atorvastatin Calcium Generic | 72 | 181 | 20 | $845 |
| Synthroid Levothyroxine Sodium | 64 | 182 | 16 | $5,895 |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 61 | 162 | 26 | $8,004 |
| Rosuvastatin Calcium Generic | 58 | 147 | 20 | $1,227 |
| Glipizide Generic | 43 | 99 | 12 | $309 |
Brand drugs: 1,044 claims; generic drugs: 829 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Karen Selk $365 ($365 in general payments such as food, travel and fees) from 2 companies. The largest payer was Amgen Inc. with $253.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.